NY State Senate Bill 2025-S2397

Current Bill Status - In Senate Committee Insurance Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 17, 2025	referred to insurance

co-Sponsors

2025-S2397 (ACTIVE) - Details

Current Committee:: Senate Insurance
Law Section:: Insurance Law
Laws Affected:: Amd §§3216, 3221 & 4303, Ins L
Versions Introduced in Other Legislative Sessions:: 2021-2022: S8549
2023-2024: S1194

2025-S2397 (ACTIVE) - Summary

Requires health insurers to provide coverage for procedures relating to the diagnosis and treatment of uterine fibroids and related conditions, including pain, discomfort and infertility resulting therefrom.

2025-S2397 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S2397       Revised   1/23/2025

SPONSOR: PERSAUD
 
TITLE OF BILL:

An act to amend the insurance law, in relation to requiring health
insurers to provide coverage for diagnosis and treatment of fibroids

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill would amend subsection (i) of 3216 of the insurance laws to
add a new paragraph 36 that states that all insurance companies cover
the cost of coverage for the treatment, symptoms, and diagnosis of
fibroids and infertility that may have been caused by fibroids.

 
SUMMARY OF PROVISIONS:

Section 1: Amends subsection (i) of section 3216 of the insurance law,
to require all insurance companies to cover costs for uterine fibroids.
Section 2 amends subsection (k) of section 3221 of the insurance law to
require every group or blanket policy to provide coverage for uterine
fibroids. Section 3 amends section 4303 of the insurance law to add

subsection (ss) which requires every medical expense indemnity corpo-
ration, hospital service, and health service corporation to provide
coverage for uterine fibroids.

 
JUSTIFICATION:

Currently, in New York State, there is no mandate that requires all
insurance companies to provide coverage for the diagnosis and/or treat-
ment of fibroids. Fibroids are usually only covered if they are causing
the patient pain or other symptoms. Some insurance companies will only
cover fibroid removal or hysterectomy when symptoms have not gone away.
This means that for people who have fibroids that are not yet causing
them pain or are seeking experimental treatments related to fibroids
their care may not be covered by health insurance. Many insurances will
only partially cover the procedure leaving patients with large copays to
fully cover the cost.

This legislation addresses the gap in insurance coverage regarding
fibroids. It would require insurance companies and other entities that
provide insurance coverage to provide coverage for all costs of diagno-
sis, symptoms, and treatment of uterine fibroids. It would also cover
infertility that was caused by fibroids. Many women do not seek treat-
ment for fibroids because they are worried it may not be covered by
insurance or that their specific treatment will not be covered by insur-
ance. This legislation would allow women with fibroids to seek treatment
without the worry that it will not be covered by their insurance provid-
er.

 
PRIOR LEGISLATIVE HISTORY:

2023/2024: 51194 Referred to Insurance

2022: S8549 Referred to Insurance

 
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS:

To be determined
 
EFFECTIVE DATE:
This Act shall take effect on the one hundred twentieth day after enact-
ment.

2025-S2397 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   2397
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                             January 17, 2025
                                ___________
 
 Introduced  by  Sens.  PERSAUD,  HOYLMAN-SIGAL -- read twice and ordered
   printed, and when printed to be committed to the Committee  on  Insur-
   ance
 
 AN  ACT  to  amend  the  insurance  law, in relation to requiring health
   insurers to provide coverage for diagnosis and treatment of fibroids

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subsection  (i)  of  section 3216 of the insurance law is
 amended by adding a new paragraph 40 to read as follows:
   (40) EVERY INSURER ISSUING A POLICY OF ACCIDENT AND  HEALTH  INSURANCE
 FOR  DELIVERY  IN  THIS  STATE  SHALL PROVIDE COVERAGE FOR ALL COSTS FOR
 DIAGNOSIS AND TREATMENT OF UTERINE FIBROIDS, ALSO CALLED  LEIOMYOMAS  OR
 MYOMAS,  AND  RELATED  CONDITIONS,  INCLUDING  BUT  NOT LIMITED TO PAIN,
 DISCOMFORT AND INFERTILITY RESULTING  THEREFROM.    SUCH  DIAGNOSIS  AND
 TREATMENT MAY INCLUDE PELVIC EXAM, ULTRASOUND, LAB TESTS, MAGNETIC RESO-
 NANCE  IMAGING,  HYSTEROSONOGRAPHY,  HYSTEROSALPINGOGRAPHY, HYSTEROSCOPY
 MEDICATION, NONINVASIVE PROCEDURES, UTERINE ARTERY EMBOLIZATION, RADIOF-
 REQUENCY ABLATION, LAPAROSCOPIC  OR  ROBOTIC  MYOMECTOMY,  HYSTEROSCOPIC
 MYOMECTOMY,  ENDOMETRIAL ABLATION, ABDOMINAL MYOMECTOMY, HYSTERECTOMY OR
 ANY OTHER TREATMENT, OR ANY COMBINATION  OF  TREATMENTS,  PROVIDED  SUCH
 TREATMENT  IS RECOMMENDED BY A HEALTH CARE PROVIDER LICENSED TO PRACTICE
 IN THE STATE OF NEW YORK.
   § 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 24 to read as follows:
   (24) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIVERY IN
 THIS STATE WHICH PROVIDES HOSPITAL, SURGICAL OR MEDICAL  COVERAGE  SHALL
 PROVIDE  COVERAGE  FOR  ALL COSTS FOR DIAGNOSIS AND TREATMENT OF UTERINE
 FIBROIDS, ALSO CALLED LEIOMYOMAS  OR  MYOMAS,  AND  RELATED  CONDITIONS,
 INCLUDING  BUT NOT LIMITED TO PAIN, DISCOMFORT AND INFERTILITY RESULTING
 THEREFROM. SUCH DIAGNOSIS AND TREATMENT MAY INCLUDE PELVIC EXAM,  ULTRA-
 SOUND, LAB TESTS, MAGNETIC RESONANCE IMAGING, HYSTEROSONOGRAPHY, HYSTER-
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD06471-01-5

 S. 2397                             2
 
 OSALPINGOGRAPHY,   HYSTEROSCOPY   MEDICATION,   NONINVASIVE  PROCEDURES,
 UTERINE ARTERY EMBOLIZATION, RADIOFREQUENCY  ABLATION,  LAPAROSCOPIC  OR
 ROBOTIC  MYOMECTOMY,  HYSTEROSCOPIC  MYOMECTOMY,  ENDOMETRIAL  ABLATION,
 ABDOMINAL MYOMECTOMY, HYSTERECTOMY OR ANY OTHER TREATMENT, OR ANY COMBI-
 NATION OF TREATMENTS, PROVIDED SUCH TREATMENT IS RECOMMENDED BY A HEALTH
 CARE PROVIDER LICENSED TO PRACTICE IN THE STATE OF NEW YORK.
   §  3.  Section  4303  of  the insurance law is amended by adding a new
 subsection (ww) to read as follows:
   (WW) EVERY MEDICAL EXPENSE  INDEMNITY  CORPORATION,  HOSPITAL  SERVICE
 CORPORATION  AND  HEALTH SERVICE CORPORATION WHICH PROVIDES COVERAGE FOR
 MEDICAL, SURGICAL OR MAJOR MEDICAL CARE SHALL PROVIDE COVERAGE  FOR  ALL
 COSTS  FOR  DIAGNOSIS  AND  TREATMENT  OF  UTERINE FIBROIDS, ALSO CALLED
 LEIOMYOMAS OR MYOMAS, AND RELATED CONDITIONS, INCLUDING BUT NOT  LIMITED
 TO  PAIN, DISCOMFORT AND INFERTILITY RESULTING THEREFROM. SUCH DIAGNOSIS
 AND TREATMENT MAY INCLUDE PELVIC EXAM, ULTRASOUND, LAB  TESTS,  MAGNETIC
 RESONANCE IMAGING, HYSTEROSONOGRAPHY, HYSTEROSALPINGOGRAPHY, HYSTEROSCO-
 PY  MEDICATION,  NONINVASIVE  PROCEDURES,  UTERINE  ARTERY EMBOLIZATION,
 RADIOFREQUENCY ABLATION, LAPAROSCOPIC OR  ROBOTIC  MYOMECTOMY,  HYSTERO-
 SCOPIC MYOMECTOMY, ENDOMETRIAL ABLATION, ABDOMINAL MYOMECTOMY, HYSTEREC-
 TOMY  OR ANY OTHER TREATMENT, OR ANY COMBINATION OF TREATMENTS, PROVIDED
 SUCH TREATMENT IS RECOMMENDED BY A  HEALTH  CARE  PROVIDER  LICENSED  TO
 PRACTICE IN THE STATE OF NEW YORK.
   § 4. This act shall take effect on the one hundred twentieth day after
 it shall have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S2397

Sponsored By

Current Bill Status - In Senate Committee Insurance Committee

co-Sponsors

2025-S2397 (ACTIVE) - Details

2025-S2397 (ACTIVE) - Summary

2025-S2397 (ACTIVE) - Sponsor Memo

2025-S2397 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S2397

Share this bill

Sponsored By

Roxanne J. Persaud

Current Bill Status - In Senate Committee Insurance Committee

co-Sponsors

Brad Hoylman-Sigal

2025-S2397 (ACTIVE) - Details

2025-S2397 (ACTIVE) - Summary

2025-S2397 (ACTIVE) - Sponsor Memo

2025-S2397 (ACTIVE) - Bill Text download pdf

Comments